USPTO serial 79458970
CELLBRICATE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with CELLBRICATE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical and biochemical preparations for use in research and laboratories, in particular reagents for pharmacological research; chemical reagents for the manufacture of cellular therapy products, in particular of cellular therapy products based on body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; chemical reagents for biological analysis of cells, in particular of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; chemical reagents for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; chemical reagents for the stimulation and/or expansion of T-cells, B-cells or natural killer cells; kits containing chemical reagents for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; kits containing chemical reagents for the stimulation and/or expansion of T-cells, B-cells or natural killer cells; chemical reagents for chromatographic immobilization, purification or isolation of cells, in particular of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; chemical reagents for the activation or stimulation of cells, in particular body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; chemical reagents for genetically modifying body cells, stem cells and cells of the immune system of mammals including human cells, T-cells, B-cells, natural killer cells and monocytes; chemical reagents for transferring genes into body cells, stem cells, and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes. | ACTIVE | — |
| 009 | Laboratory apparatus for the manufacture of cellular therapy products, in particular of cellular therapy products based on body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; scientific apparatus for biological analysis of cells, in particular of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; scientific apparatus for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; scientific apparatus for the stimulation and/or expansion of T-cells, B-cells or natural killer cells; laboratory apparatus for the manufacture of cellular therapy products, in particular of cellular therapy products based on body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes, the apparatus including a body fluid collection unit, a cell processing unit and a unit for releasing the manufactured cellular therapy unit; scientific apparatus for the washing of cells obtained from a biological sample, in particular for washing of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; laboratory apparatus for the manufacture of cellular therapy products including apparatus for the chromatographic immobilization, purification or isolations of cells and apparatus for the transfer of genes into cells, in particular of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; laboratory apparatus for the manufacture of cellular therapy products including apparatus for the chromatographic immobilization, purification or isolations of cells, apparatus of activation or stimulation of cells, and apparatus for the transfer of genes into cells, in particular of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes. | ACTIVE | — |
| 042 | Scientific services and research relating thereto in the fields of biology, chemistry, medicine, immunology, oncology, molecular biology, cellular biology, biochemistry and/or medicinal chemistry as well as in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, in particular cellular therapy products, including body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes, diagnostic preparations and biomarker reagents and/or diagnostic apparatus. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 25, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 25, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 24, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |